Cost-Minimization Analyses of Adalimumab Compared with Selective Immunosuppressive Cytokines Blockers and Inhibitors of Tumor Necrosis Factor Alpha Indicated for the Treatment of Rheumatoid Arthritis, Psoriasis and Crohn’s Disease in the Private Market in Mexico
1996 ◽
pp. 143-152
2016 ◽
Vol 36
(5)
◽
pp. 625-633
◽
2008 ◽
Vol 27
(10)
◽
pp. 1243-1248
◽
2014 ◽
Vol 31
(4)
◽
pp. 564-571
◽